CCM
AMGN icon

Copernicus Capital Management’s Amgen AMGN Stock Holding History

Copernicus Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33,000
Closed -$7.78M – 19
2020
Q2 		$7.78M Buy
+33,000
New +$7.53M 8.53% 4

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Copernicus Capital Management's AMGN Position: Q3 2020 in Review

Copernicus Capital Management sold out of Amgen (AMGN) in Q3 2020, closing a stake of 33,000 shares — an estimated $7.78M sold.

Copernicus Capital Management first reported a position in AMGN in Q2 2020 and held it in 1 quarter. The position peaked at $7.78M in Q2 2020. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Copernicus Capital Management reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Copernicus Capital Management sold 33,000 Amgen shares in Q3 2020, an estimated $7.78M.
  • Copernicus Capital Management first reported a position in Amgen in Q2 2020 and held it in 1 quarter.
  • Copernicus Capital Management's Amgen position peaked at $7.78M in Q2 2020.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Copernicus Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.